Integrated genomic analysis of recurrence-associated small non-coding RNAs in oesophageal cancer
暂无分享,去创建一个
Leng Han | Kyong-Ah Yoon | Yoon-La Choi | Jungnam Joo | Han Liang | Moon Soo Kim | Sang Bae Kim | Jared K Burks | David J Sugarbaker | Young Mog Shim | Hee-Jin Jang | J. Joo | Yong Sun Lee | D. Sugarbaker | Ju-Seog Lee | Jong-Lyul Park | Y. Shim | Han Liang | B. Sohn | K. Yoon | J. Burks | Yoon-La Choi | Jong Mog Lee | J. Zo | Leng Han | Hee-Jin Jang | Hyun-Sung Lee | B. Burt | G. Lee | Yun-Yong Park | S. Kim | Sang Cheol Kim | J. Yun | K. Na | Seon-Young Kim | D. Mak | Bo Hwa Sohn | Ju-Seog Lee | Sang Cheol Kim | Hyun-Sung Lee | Geon Kook Lee | Jae Ill Zo | Bryan M Burt | Yun-Yong Park | Jong-Lyul Park | Ju Sik Yun | Kook Joo Na | Seon-Young Kim | Duncan Mak | Seon-Young Kim | G. Lee | Yun‐Yong Park | Hyun-Sung Lee | Sang Bae Kim | Yoon‐La Choi | Seon-Young Kim
[1] Li Shang,et al. Genomic and molecular characterization of esophageal squamous cell carcinoma , 2014, Nature Genetics.
[2] I. Wistuba,et al. TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs , 2010, Nature.
[3] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[4] I. Amelio,et al. MicroRNAs and p63 in epithelial stemness , 2014, Cell Death and Differentiation.
[5] Hongwei Zhang,et al. The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma , 2010, Annals of surgery.
[6] Eli Gilboa,et al. The determinants of tumour immunogenicity , 2012, Nature Reviews Cancer.
[7] Sean C. Bendall,et al. Extracting a Cellular Hierarchy from High-dimensional Cytometry Data with SPADE , 2011, Nature Biotechnology.
[8] The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.
[9] A. Schetter,et al. MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival , 2009, Clinical Cancer Research.
[10] P. Qiu. Inferring Phenotypic Properties from Single-Cell Characteristics , 2012, PloS one.
[11] Yong Sun Lee,et al. nc886, a non-coding RNA of anti-proliferative role, is suppressed by CpG DNA methylation in human gastric cancer , 2014, Oncotarget.
[12] E. Montgomery,et al. microRNA 223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1 , 2013, Clinical Cancer Research.
[13] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[14] Yong Soo Choi,et al. Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Carsten Denkert,et al. Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization , 2012, PloS one.
[16] A. Regev,et al. SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.
[17] Yong Sun Lee,et al. Epigenetic silencing of the non-coding RNA nc886 provokes oncogenes during human esophageal tumorigenesis , 2014, Oncotarget.
[18] Steven J. M. Jones,et al. Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.
[19] M. Ladanyi,et al. Squamous-cell carcinomas of the lung: emerging biology, controversies, and the promise of targeted therapy. , 2012, The Lancet. Oncology.
[20] L. Crinò,et al. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.
[21] Jian Sun,et al. Genetic landscape of esophageal squamous cell carcinoma , 2014, Nature Genetics.
[22] P. Sharma,et al. The future of immune checkpoint therapy , 2015, Science.
[23] Kazuhiro Yoshida,et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. , 2010, The Lancet. Oncology.
[24] Howard Y. Chang,et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis , 2010, Nature.
[25] Ying Sun,et al. Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. , 2012, The Lancet. Oncology.
[26] Vinod Scaria,et al. Consensus miRNA expression profiles derived from interplatform normalization of microarray data. , 2010, RNA.
[27] James B. Shealy,et al. miR-1269 Promotes Metastasis and Forms a Positive Feedback Loop with TGF-β , 2015, Nature Communications.
[28] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[29] Benjamin E. Gross,et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.
[30] Dustin E. Schones,et al. Genome-wide Mapping of HATs and HDACs Reveals Distinct Functions in Active and Inactive Genes , 2009, Cell.
[31] J. Ferlay,et al. Global incidence of oesophageal cancer by histological subtype in 2012 , 2014, Gut.
[32] David M. Woods,et al. HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade , 2015, Cancer Immunology Research.
[33] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[34] Heidi J. Peltier,et al. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. , 2008, RNA.
[35] Fang Zhou,et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. , 2008, Cancer research.
[36] Fang Zhou,et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma , 2014, Gut.
[37] Sean C. Bendall,et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia , 2013, Nature Biotechnology.
[38] Masayuki Kano,et al. miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma , 2010, International journal of cancer.
[39] Steven J. M. Jones,et al. Comprehensive molecular characterization of urothelial bladder carcinoma , 2014, Nature.
[40] J R Siewert,et al. Esophageal Carcinoma , 2000, Recent Results in Cancer Research.
[41] F. Speleman,et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.
[42] Qiang Feng,et al. Identification of genomic alterations in oesophageal squamous cell cancer , 2014, Nature.
[43] H. Morgenstern,et al. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus , 2006, International journal of cancer.
[44] Yong Sun Lee,et al. Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. , 2011, RNA.
[45] Frank Speleman,et al. A novel and universal method for microRNA RT-qPCR data normalization , 2009, Genome Biology.
[46] Sung-Liang Yu,et al. MicroRNA signature predicts survival and relapse in lung cancer. , 2008, Cancer cell.
[47] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[48] W. Tan,et al. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population , 2001, International journal of cancer.
[49] Yoshimasa Tanaka,et al. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer , 2007, Proceedings of the National Academy of Sciences.
[50] J. Vandesompele,et al. MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer , 2010, BMC Cancer.